Schwab Andrew J.'s Form 4 filing
Skye Bioscience, Inc. (SKYE) · filed Aug 22, 2025
- Accession no.
- 0001415889-25-022808
- Filed
- Aug 22, 2025
- Trade date
- Aug 21-22, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $800.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schwab Andrew J.CIK 0001598549 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2025 | Common Stock | SSaleDisposed | −58,642 | $3.57 | −$209,351.94 | 1,621,043 | Indirect | |
| Aug 21, 2025 | Common Stock | SSaleDisposed | −2,314 | $3.57 | −$8,260.98 | 63,963 | Indirect | |
| Aug 22, 2025 | Common Stock | SSaleDisposed | −163,979 | $3.42 | −$560,808.18 | 1,457,064 | Indirect | |
| Aug 22, 2025 | Common Stock | SSaleDisposed | −6,470 | $3.42 | −$22,127.4 | 57,493 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.